Article Text

Download PDFPDF

Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia
  1. B. M. Ansari,
  2. E. N. Thompson


    Two cases of refractory acute myeloid leukaemia were treated with methoxy-9-ellipticine lactate alone and in combination with other chemotherapeutic agents. In the first patient a successful complete second and third remission was achieved lasting 2 and 3 months respectively. However, a partial remission was obtained in the second patient as treatment with methoxy-9-ellipticine was only started in the terminal phase of the illness. In view of the resistance of this form of leukaemia to present chemotherapeutic drugs both initally and at the time of relapse, the response of these two cases to methoxy-9-ellipticine is worth reporting.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.